Can We Prevent Resistance to Osimertinib? Combination or Sequential

J Thorac Oncol. 2018 Jul;13(7):877-879. doi: 10.1016/j.jtho.2018.05.012.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Acrylamides
  • Aniline Compounds
  • ErbB Receptors / genetics
  • Humans
  • Lung Neoplasms*
  • Mutation Accumulation*
  • Piperazines

Substances

  • Acrylamides
  • Aniline Compounds
  • Piperazines
  • osimertinib
  • ErbB Receptors